Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 2
This trial is looking at a drug called vandetanib alongside a type of hormone therapy drug called fulvestrant. It is for post menopausal women with breast cancer that has spread into tissue surrounding the breast (is locally advanced) or to another part of the body and has receptors for the hormone oestrogen (is ER positive). This trial is supported by Cancer Research UK.
Recruitment start: 20 April 2015
Recruitment end: 31 October 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mark Beresford Dr Robert Jones
AstraZeneca
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Velindre NHS Trust
This is Cancer Research UK trial number CRUK/13/029
Last reviewed: 31 Oct 2017
CRUK internal database number: 11760